Journal of Urologic Oncology

Editorial

November 30, 2024

Editorial for JUO 2024 Vol. 22 No. 3 - Rethinking Urologic Oncology Surgery

Cheol Kwak

J Urol Oncol. 2024;22(3):185-187.

Original Article

November 30, 2024

Early Experience of the Single-Port Robotic Transvesical Radical Prostatectomy: Case Series

Jae Hoon Chung, Hwanik Kim, Woo Jin Bang, et al.

J Urol Oncol. 2024;22(3):188-195.

Purpose: This study evaluated the feasibility and safety of single-port transvesical robotic radical prostatectomy. Materials and Methods: Four patients underwent a transvesical robotic radical prostatectomy using a singleport robotic system. The...

Original Article

November 30, 2024

Simultaneous Prostate Target Biopsy Integrated With Radical Prostatectomy: A Pilot Study Omitting Preoperative Systematic Biopsy

Tae Young Park, Jae Young Hwang, Seong Woo Yun, et al.

J Urol Oncol. 2024;22(3):196-200.

Purpose: This study evaluates the viability of a new method that employs transperineal targeted biopsy with frozen section analysis immediately followed by robot-assisted radical prostatectomy (RARP), bypassing the traditional systematic...

Original Article

November 30, 2024

A Machine Learning Model for Prostate Cancer Prediction in Korean Men

Sukjung Choi, Beomgi So, Shane Oh, et al.

J Urol Oncol. 2024;22(3):201-210.

Purpose: Unnecessary prostate biopsies for detecting prostate cancer (PCa) should be minimized. Therefore, this study developed a machine learning (ML) model to predict PCa in Korean men and evaluated its...

Original Article

November 30, 2024

Assessing Patient Risk, Benefit, and Outcomes in Drug Development: A Decade of Abiraterone Clinical Trials

Matthew Rashid, Eli Oldham, Griffin K. Hughes, et al.

J Urol Oncol. 2024;22(3):211-223.

Purpose: Our study aimed to evaluate the risk and benefit profiles of clinical trials using abiraterone in cancer treatment. Materials and Methods: A comprehensive search was conducted on May 24, 2023,...

Brief Report

November 30, 2024

The Current Role of Metastasis-Directed Therapy for Oligometastatic Renal Cell Carcinoma

Hyung Joon Kim

J Urol Oncol. 2024;22(3):224-227.

Approximately 20% of newly diagnosed renal cell carcinoma (RCC) cases exhibit synchronous metastases, while 20% to 40% of initially localized RCC cases subsequently develop distant metastases after surgical intervention. In...

Invited Review

November 30, 2024

Exploring the Evolving Role of Metastasectomy in Advanced Renal Cell Carcinoma

Jongkyou Kwon, Sungun Bang, Kang Su Cho

J Urol Oncol. 2024;22(3):228-236.

In the treatment of metastatic lesions in advanced renal cell carcinoma (RCC), no clear consensus exists regarding whether immunotherapy should be combined with surgical resection or metastasectomy. Systemic therapies have...

Original Article

November 30, 2024

Clinical Application of Artificial Intelligence-Based Computed Tomography Analysis of Myosteatosis in Localized Renal Cell Carcinoma

Byeong Jin Kang, Kyung Hwan Kim, Seung Baek Hong, et al.

J Urol Oncol. 2024;22(3):237-245.

Purpose: Myosteatosis, defined as fat infiltration in muscle tissue, has been linked to poor outcomes in various cancers. However, the prognostic impact of myosteatosis on renal cell carcinoma (RCC) remains...

Invited Review

November 30, 2024

The Emerging Treatment of BCG (Bacillus Calmette-Guérin)-Unresponsive Non–Muscle-Invasive Bladder Cancer

Jong Ho Park, Jong Jin Oh

J Urol Oncol. 2024;22(3):246-255.

Bacillus Calmette-Guérin (BCG) remains the cornerstone in the treatment of high-risk non-muscle-invasive bladder cancer (NMIBC), effectively preventing recurrence and progression. Unfortunately, a significant proportion of patients are classified as BCG-unresponsive,...

Invited Review

November 30, 2024

Trimodal Therapy in the Treatment of Muscle-Invasive Bladder Cancer

Yongsoo Jo, Hyeong Dong Yuk

J Urol Oncol. 2024;22(3):256-267.

This review examines the evolution, clinical efficacy, and future directions of trimodal therapy (TMT) as a bladder-preserving treatment option for muscle-invasive bladder cancer. A nonsystematic literature search was conducted on...

Review Article

November 30, 2024

Artificial Intelligence: The Latest Advances in the Diagnosis of Bladder Cancer

Satyendra Singh, Ram Mohan Shukla

J Urol Oncol. 2024;22(3):268-280.

Bladder cancer remains a significant health challenge. Early and accurate diagnoses are crucial for effective treatment and improved patient outcomes. In recent years, artificial intelligence (AI) has emerged as a...

Correction

September 11, 2024

Correction: Addendum of Informed Consent Statements

J Urol Oncol. 2024;22(3):281-281.

Expression of Concern

November 30, 2024

Expression of Concern: Rare Ewingoid Dedifferentiated Liposarcoma of the Spermatic Cord Causing Testicular Artery Compression: A Case Report

J Urol Oncol. 2024;22(3):282-282.

Editorial for JUO 2024 Vol. 22 No. 3 - Rethinking Urologic Oncology Surgery Cheol Kwak J Urol Oncol. 2024;22(3):185-187. Editorial Nov 30, 2024 Full text PubReader ePub PDF	Early Experience of the Single-Port Robotic Transvesical Radical Prostatectomy: Case Series Jae Hoon Chung, Hwanik Kim, Woo Jin Bang, et al. J Urol Oncol. 2024;22(3):188-195. Cited By 1 Original Article Nov 30, 2024 Prostate Cancer Full text PubReader ePub PDF
Simultaneous Prostate Target Biopsy Integrated With Radical Prostatectomy: A Pilot Study Omitting Preoperative Systematic Biopsy Tae Young Park, Jae Young Hwang, Seong Woo Yun, et al. J Urol Oncol. 2024;22(3):196-200. Cited By 1 Original Article Nov 30, 2024 Prostate Cancer Full text PubReader ePub PDF	A Machine Learning Model for Prostate Cancer Prediction in Korean Men Sukjung Choi, Beomgi So, Shane Oh, et al. J Urol Oncol. 2024;22(3):201-210. Cited By 1 Original Article Nov 30, 2024 Prostate Cancer Full text PubReader ePub PDF
Assessing Patient Risk, Benefit, and Outcomes in Drug Development: A Decade of Abiraterone Clinical Trials Matthew Rashid, Eli Oldham, Griffin K. Hughes, et al. J Urol Oncol. 2024;22(3):211-223. Cited By 1 Original Article Nov 30, 2024 Prostate Cancer Full text PubReader ePub PDF	The Current Role of Metastasis-Directed Therapy for Oligometastatic Renal Cell Carcinoma Hyung Joon Kim J Urol Oncol. 2024;22(3):224-227. Cited By 1 Brief Report Nov 30, 2024 Kidney Cancer Full text PubReader ePub PDF
Exploring the Evolving Role of Metastasectomy in Advanced Renal Cell Carcinoma Jongkyou Kwon, Sungun Bang, Kang Su Cho J Urol Oncol. 2024;22(3):228-236. Cited By 1 Invited Review Nov 30, 2024 Kidney Cancer Full text PubReader ePub PDF	Clinical Application of Artificial Intelligence-Based Computed Tomography Analysis of Myosteatosis in Localized Renal Cell Carcinoma Byeong Jin Kang, Kyung Hwan Kim, Seung Baek Hong, et al. J Urol Oncol. 2024;22(3):237-245. Cited By 1 Original Article Nov 30, 2024 Kidney Cancer Full text PubReader ePub PDF
The Emerging Treatment of BCG (Bacillus Calmette-Guérin)-Unresponsive Non–Muscle-Invasive Bladder Cancer Jong Ho Park, Jong Jin Oh J Urol Oncol. 2024;22(3):246-255. Cited By 1 Invited Review Nov 30, 2024 Bladder Cancer Full text PubReader ePub PDF	Trimodal Therapy in the Treatment of Muscle-Invasive Bladder Cancer Yongsoo Jo, Hyeong Dong Yuk J Urol Oncol. 2024;22(3):256-267. Cited By 1 Invited Review Nov 30, 2024 Bladder Cancer Full text PubReader ePub PDF
Artificial Intelligence: The Latest Advances in the Diagnosis of Bladder Cancer Satyendra Singh, Ram Mohan Shukla J Urol Oncol. 2024;22(3):268-280. Cited By 1 Review Article Nov 30, 2024 Bladder Cancer Full text PubReader ePub PDF	Correction: Addendum of Informed Consent Statements J Urol Oncol. 2024;22(3):281-281. Corrects: 2022;20(1):59 Corrects: 2022;20(2):133 Correction Sep 11, 2024 Full text PubReader ePub PDF
Expression of Concern: Rare Ewingoid Dedifferentiated Liposarcoma of the Spermatic Cord Causing Testicular Artery Compression: A Case Report J Urol Oncol. 2024;22(3):282-282. Expression of concern: 2022;20(4):273 Expression of Concern Nov 30, 2024 Full text PubReader ePub PDF

6,025	New Drugs for Bacillus Calmette Guérin-Unresponsive Nonmuscle Invasive Bladder Cancer
5,499	The Important Role of Poly ADP-Ribose Polymerase Inhibitor in Prostate Cancer
5,006	An Update of Prostate-Specific Membrane Antigen Theranostics in Prostate Cancer
4,841	Complex Epidemiology of Prostate Cancer in Asian Countries
4,692	The Present and Future of Intravesical Therapy in Bladder Cancer

Cited By 9	Epidemiology of Urologic Cancer in Korea: Nationwide Trends in the Last 2 Decades
Cited By 4	An Update of Prostate-Specific Membrane Antigen Theranostics in Prostate Cancer
Cited By 4	Complex Epidemiology of Prostate Cancer in Asian Countries
Cited By 3	The Evolving Role of Checkpoint Inhibitors in the Treatment of Urothelial Carcinoma: A Literature Review of Practice-Changing Trials
Cited By 2	Prostate Imaging and Reporting and Data System Version 2.1: Limitations for Clinical Use